Crohn’s Disease
Crohn’s disease is a form of inflammatory bowel disease, a qualifying category in Georgia’s Medical Cannabis Patient Registry. Adults with a documented diagnosis can discuss eligibility with a Georgia-licensed physician. Certification depends on medical judgment; it is not automatic and does not establish that cannabis will control bowel inflammation.
$100 · Private 15-minute phone consultation with a Georgia-licensed physician. GMMC serves adults age 18 and older throughout Georgia.
Book on Calendly. Our team sends an eVisit link for the telemedicine visit. Payment is collected through eVisit after the visit. If our physician determines that the patient does not qualify for medical cannabis certification, we will refund any consultation fee paid. State card fees are separate.
This guide explains medical marijuana for Crohn's disease, the limits of current research, and the consultation process. Continue working with your gastrointestinal specialist. A medical marijuana card does not replace treatment aimed at reducing inflammation or preventing complications.
Does Crohn's Disease Qualify in Georgia?
The Georgia Department of Public Health's current patient guidance lists inflammatory bowel disease. Crohn’s disease falls within that category. A physician reviews the diagnosis, medical history, and eligibility before deciding whether to certify.
The current category is broader than Crohn’s disease alone. Patients with another diagnosed inflammatory bowel disease should discuss their individual situation with the physician. Ordinary abdominal discomfort or an unconfirmed diagnosis should not be treated as proof of eligibility.
GMMC provides consultations for adults throughout Georgia, including Atlanta and communities elsewhere in the state. You do not need to live near the clinic to ask about an appointment.
Prepare available GI records and a current medication list. The physician determines which documentation and evaluation are needed. Booking an appointment or paying a consultation fee does not guarantee certification, registry enrollment, or a treatment outcome.
If you are still being evaluated for a possible diagnosis, continue that assessment with your treating doctor. The GMMC appointment is an eligibility consultation; it should not be used to bypass diagnostic care.
Understanding Crohn's Disease and Its Symptoms
NIH's digestive health information describes Crohn’s disease as a chronic inflammatory condition affecting the digestive tract. It is one form of inflammatory bowel disease, alongside ulcerative colitis.
The NIDDK symptom guide identifies diarrhea, abdominal cramping or pain, and weight loss as common symptoms. Fatigue, nausea, appetite loss, fever, and symptoms affecting the joints, eyes, or skin may also occur.
Symptoms can differ between people and change over time. Your history matters more than an online description of a typical patient. Explain which symptoms are new, which persist between flares, and which interfere with daily life.
The exact cause is not fully understood. Researchers study the immune response, genes, environmental factors, and the gut microbiome. A theory about cannabis affecting one pathway does not establish that it treats the disease.
If pain, nausea, or another symptom changes substantially, contact the treating team for assessment. Do not assume every symptom comes from Crohn’s or wait for a cannabis evaluation to address urgent concerns.
Treatment Options and Ongoing GI Care
The NIDDK treatment resource explains that treatment aims to lower inflammation, prevent flares, and maintain remission. Depending on the person, it may involve medicines or surgery.
Prescription treatment options include corticosteroids, immunosuppressants, biologics, and other medicines selected by the treating doctor. Surgery may be needed for some complications. Decisions depend on disease location, severity, prior response, and other health factors.
Do not stop or change prescribed Crohn’s medicines because you feel better after using cannabis. Ask your GI specialist before making treatment changes. Symptom management and control of the underlying inflammation are related but different goals.
When discussing potential benefits, ask how disease activity will be assessed. A person’s report of less discomfort does not by itself establish healing of the gastrointestinal tract. Your specialist determines which monitoring is appropriate.
GMMC’s medical cannabis consultation does not replace gastroenterology follow-up, monitoring of prescribed drugs, or assessment of new complications. Keep each clinician informed so that a proposed additional approach does not conflict with the existing care plan.
What Research Says About Medical Cannabis
Cannabis contains cannabinoids such as THC and CBD. Researchers study how these compounds interact with biological systems, including the endocannabinoid system. Laboratory findings and possible mechanisms need clinical testing before becoming treatment claims.
The cannabis plant is the source of varied preparations. A study of one extract cannot establish the efficacy of every product, dose, or route. Medical cannabis patients should be able to discuss the evidence without being promised significant relief.
A Randomized Crohn's Disease Trial
A 2021 randomized, placebo-controlled trial evaluated an oral CBD-rich cannabis oil containing THC in 56 patients over eight weeks. Clinical symptom scores and quality-of-life measures improved, but endoscopic scores and inflammatory markers did not show significant improvement.
The investigators recommended restricting cannabis treatment for Crohn’s disease to clinical trials until more evidence became available. Their findings should not be represented as proof that cannabis reduces bowel inflammation or provides disease-modifying treatment.
This trial offers a reason to study symptom outcomes further. It does not establish long-term safety, prevention of complications, or benefit for every patient. The preparation studied also differs from an unspecified CBD product.
What a Later Meta-Analysis Adds
A 2025 systematic review and meta-analysis reported promising clinical findings from randomized trials, but did not find a statistically significant reduction in C-reactive protein compared with placebo. The authors called for larger, standardized studies to clarify effectiveness and safety.
A pooled result needs careful interpretation. Studies may use different products and measures, and a clinical score is not interchangeable with an inflammatory biomarker. The review does not establish that medical marijuana cures Crohn’s disease.
Ask the physician which findings are relevant to your situation rather than relying on a headline. The question is not simply whether a study was positive; it is what improved, what did not, and how certain the result is.
Symptom Relief Is Different From Inflammation Control
Some research suggests symptom improvements, but this should remain clearly separated from control of the disease process. Pain, appetite, nausea, sleep, and daily functioning are important to patients. Improvement in one area does not prove that intestinal inflammation has resolved.
Do not assume that feeling less pain means a prescribed medicine is no longer necessary. Continue the monitoring and treatment plan recommended by your GI specialist. Discuss the change in symptoms so the team can interpret it in context.
Many patients want to know whether cannabis could help them work, eat, or rest more comfortably. Those are reasonable questions for an evaluation. GMMC does not guarantee symptom relief, remission, reduced medication use, or improved quality of life.
Discussing Symptoms During the Consultation
Prepare a short description of what is most difficult now. Instead of listing every possible benefit of marijuana use, explain your own symptoms and priorities. This helps the physician understand why you are seeking the consultation.
Examples of useful information include:
How abdominal pain affects your daily activities.
Whether nausea or appetite loss is interfering with eating.
Recent changes in weight or bowel symptoms.
Whether insomnia, anxiety, or stress affects your day.
Which prescribed treatments you use and how they have worked.
Previous cannabis use and any unwanted effects.
These are topics to discuss, not a list of symptoms cannabis is proven to alleviate. The physician may ask about additional evaluation or explain why a particular concern should be addressed with your GI team first.
It is also useful to distinguish a long-standing issue from a recent change. Bring relevant information from the treating clinician where available. Do not delay care for a new or worsening problem while waiting for an eligibility appointment.
Questions That Keep Expectations Clear
Ask what the research supports for the symptom you are discussing. Ask which potential side effects matter given your medicines and health history. Ask who should be contacted if symptoms change.
A practical goal might be understanding whether certification is appropriate while preserving your current treatment plan. It should not require a promise that cannabis will replace medicine, prevent surgery, or control all symptoms.
If a clinician discusses possible medical use, clarify who will monitor it. Do not assume that the eligibility consultation includes ongoing dosing management or specialist GI care. Contact the team about the actual service before booking if you need additional arrangements.
Risks and Potential Side Effects
NIH's cannabis health resource describes effects on memory, attention, movement, and mood. Cannabis can cause dizziness, drowsiness, anxiety, and other unwanted effects. THC can impair a person even when a product is obtained for medical use.
Tell the physician about your mental health history, other health conditions, and past reactions. A product that another patient tolerated may not be appropriate for you. CBD products should not be assumed to be risk free simply because they do not produce the same intoxication as THC.
Discuss your full medication list, including prescriptions, nonprescription drugs, supplements, and cannabis already being used. A clinician or pharmacist should review potential interactions. This page does not identify a universally safe combination.
Do not drive or operate machinery while impaired. Ask the clinician how safety considerations fit with work, transportation, or caregiving responsibilities. A medical card does not remove the need to avoid impairment.
If nausea, vomiting, pain, or another symptom worsens after cannabis use, contact the treating clinician rather than assuming it is a Crohn’s flare. Keep the team informed of the product and pattern of use so that the assessment is based on complete information.
Products, Dosage, and Physician Guidance
This page does not recommend a cannabis strain, THC:CBD ratio, administration route, or dosage. Product strength and composition can vary, and a study preparation is not automatically equivalent to one sold elsewhere.
Ask the physician whether a proposed product is appropriate for your circumstances. Do not copy a trial dose, another person’s routine, or instructions from a social media post. A prescription medicine and a state-program cannabis product also have different regulatory pathways.
The FDA explains that specific cannabinoid-related prescription drugs have approved indications. Those approvals do not establish that dispensary cannabis or retail CBD is approved to treat Crohn’s disease.
For current product rules and authorized sellers, use the Georgia Access to Medical Cannabis Commission. Verify the source rather than assuming that an online vendor, pharmacy, or dispensary in another state is an authorized Georgia seller.
Discuss any treatment changes with your GI specialist. Product selection is not a substitute for assessing inflammation, nutritional needs, or complications. A medical cannabis card provides access within the program; it is not a certificate of product effectiveness.
Preparing for Your GMMC Appointment
Gather available records without creating an unnecessarily complicated file. The physician decides what documentation is needed. A concise history and medication list can help focus the conversation.
Have access to:
Available GI specialist notes or diagnosis documentation.
Relevant colonoscopy, imaging, or laboratory reports if available.
A complete medication and supplement list.
Notes about prior treatment response and unwanted effects.
Your main questions about eligibility and safety.
Current identification and any needed Georgia residency documentation.
If records need to be submitted, ask the team for the appropriate secure process. Do not upload medical records or identifiers into public website chat or a general public inquiry.
Choose a private place where you can participate in the phone consultation. Our team sends an eVisit link after you book. If you have questions about accessing the visit or participating, contact GMMC before the appointment.
You do not need to buy cannabis to prepare for an evaluation. Start with the medical review and eligibility decision. Do not change your current medications in anticipation of the appointment.
A Simple Appointment Checklist
Before the visit, write down your most important question, check that the medication list is current, and have available diagnosis information ready. Confirm how you will receive the eVisit link.
During the visit, describe symptoms accurately and tell the physician about prior marijuana use. Ask what the next step is if more records or evaluation are needed. Approval is based on the review rather than on how many symptoms you list.
After the visit, follow the physician’s instructions. If certification is appropriate, you must complete the separate state registry process and follow any required next steps. Continue your GI care and keep the treating team informed about any proposed cannabis use.
Booking, Payment, and Refunds
GMMC offers a $100 private 15-minute phone consultation with a Georgia-licensed physician for adults age 18 and older. The same booking process applies statewide.
Book the appointment on Calendly.
Our team sends the eVisit link for your telemedicine visit.
Attend the consultation and discuss eligibility and your medical history.
Payment is collected through eVisit after the visit.
If our physician determines that you do not qualify, any consultation fee paid will be refunded.
This is a consultation service. There is no merchandise to return or replace. State card fees and any cannabis purchase are separate from GMMC’s consultation fee.
Booking does not guarantee approval, a particular product recommendation, or symptom improvement. The refund applies to the consultation fee paid when our physician determines that you do not qualify for medical cannabis certification.
For general booking assistance, visit our contact page. Ask administrative questions there and use the appropriate private process for clinical information.
Georgia Registry Steps After Certification
After physician certification, DPH reviews the submission, and registered patients receive instructions for paying the state card fee. Its patient guidance lists a $30 fee plus a $3.75 online service fee, five-year card validity, and up to 10 business days from processed payment to receipt. Its program guidance also describes annual physician certification. Georgia law exempts patients with incurable or irreversible conditions from annual certification. Confirm whether this applies to your documented condition and registry record with your certifying physician or Georgia DPH. Review the certification exception and card renewal.
Read the state instructions and respond if more documentation is requested. Your consultation receipt does not complete every registry step. State processing and product purchasing are separate from the physician appointment.
Use official state resources for current Georgia law and purchasing requirements. Do not assume that a Georgia card creates permission to transport cannabis across state lines or overrides federal law and other jurisdictions.
Keep track of the card expiration date and physician certification requirements. If you already have an unexpired card, ask about your circumstances before treating the appointment as a new-patient application. Our renewal information may help you prepare general questions.
Frequently Asked Questions
Is Crohn's Disease a Qualifying Condition?
Georgia lists inflammatory bowel disease, which includes Crohn’s disease. A Georgia-licensed physician still evaluates eligibility and determines whether certification is appropriate.
Does Medical Marijuana Cure Crohn's Disease?
No. Current research does not establish a cure or reliable control of bowel inflammation. Some clinical studies report symptom improvements, which are different from evidence that the disease itself is controlled.
Can I Stop My Prescribed Crohn's Medicines?
Do not stop or adjust prescribed treatment based on this page. Discuss changes with your GI specialist, even if symptoms feel better.
Does Cannabis Reduce Inflammation?
The cited Crohn’s trial did not show significant improvement in inflammatory markers or endoscopic scores. A proposed mechanism or personal symptom improvement does not establish disease-modifying benefit.
Can I Book From Outside Atlanta?
Yes. GMMC serves adults throughout Georgia. Booking is through Calendly, and our team sends an eVisit link for the telemedicine visit.
Is the Consultation for Adults Only?
Yes. GMMC serves patients age 18 and older. This page describes the adult service.
Do I Pay Through Shopify?
Payment is collected through eVisit after the telemedicine visit. Calendly is used for booking. State registry fees and product costs are separate.
What Happens if I Do Not Qualify?
If our physician determines that you do not qualify for medical cannabis certification, we will refund any consultation fee paid.
Does the Card Guarantee a Product Will Help?
No. Eligibility, access, safety, and effectiveness are separate questions. A card does not promise relief or make every product appropriate for every person.
What Records Should I Prepare?
Have available diagnosis information, GI notes, and a current medication list ready. The physician determines what is needed. Ask about secure submission if records are requested.
Can I Use Retail CBD Instead of Crohn's Treatment?
Do not replace prescribed Crohn’s treatment with retail CBD. Discuss any proposed use with your GI specialist and disclose it in the consultation.
What if My Symptoms Are Getting Worse?
Contact your treating team for assessment. An eligibility visit does not replace urgent care or evaluation of a possible complication.
Book an Adult Eligibility Consultation
If you have a diagnosed inflammatory bowel disease and want to discuss Georgia medical cannabis eligibility, GMMC offers a $100 private 15-minute phone consultation with a Georgia-licensed physician.
Book through Calendly, receive the eVisit link from our team, and attend the consultation. Payment is collected through eVisit after the visit. If the physician determines that you do not qualify, any consultation fee paid will be refunded.
Continue working with your GI specialist on treatment and monitoring. The consultation can clarify eligibility and questions about the next step without promising a cure or guaranteed relief.